GUGGENHIME ANDREW
PRESIDENT AND CFO
GUGGENHIME ANDREW has filed 10 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, GUGGENHIME ANDREW is listed as PRESIDENT AND CFO at Vaxcyte, Inc. Inside the rolling window, GUGGENHIME ANDREW reported no open-market purchases and 3 open-market sales totaling $1.6M in PCVX. The largest disclosed transaction in the window is a sale of 10,000 PCVX shares on Jul 6, 2026, worth $573K.
Companies traded
Other insiders at PCVX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GUGGENHIME ANDREW made?
GUGGENHIME ANDREW has filed 10 SEC Form 4 filings (21 transaction rows) across 1 company since 2025.
Which companies does GUGGENHIME ANDREW trade?
GUGGENHIME ANDREW has filed SEC Form 4 disclosures for 1 company, including PCVX.
When was GUGGENHIME ANDREW's most recent SEC Form 4 filing?
GUGGENHIME ANDREW's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is GUGGENHIME ANDREW's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, GUGGENHIME ANDREW is listed as PRESIDENT AND CFO.
What is GUGGENHIME ANDREW's total buy and sell value in the current window?
Inside the rolling retention window, GUGGENHIME ANDREW bought $0 and sold $1.6M based on SEC Form 4 filings.
What was GUGGENHIME ANDREW's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 PCVX shares on 2026-07-06, worth $573K, per SEC Form 4 filings.